Sign in
Taking people in United StatesEarly phase 1

Comparing two misoprostol doses to start labor in women with severe obesity

Compares two misoprostol doses to start labor in adult women with severe obesity.

Key facts

Who runs it
University of Maryland, Baltimore
Where
Baltimore, United StatesSee the site
Trial code
Registry title
Induction of Labor in Morbidly Obese Patients
Status
Recruiting
Phase
Early phase 1
People taking part
162 people, planned
Started
15 Jul 2024
Expected to end
May 2027
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Misoprostol
Record updated
29 July 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for pregnant women with a BMI of 40 or more who are coming in for induction of labor. It compares two doses of misoprostol.

Age
18 years or older
Sex
Women only
Disease stage
Morbid obesity (BMI 40 kg/m2 or more) at admission; single baby head-down, 34 weeks 0 days to 42 weeks 6 days of pregnancy; cervix opened less than 5 cm (2 in); fewer than 5 contractions per 10 minutes
Earlier treatment
No earlier cesarean delivery

Main reasons for not taking part

  • Earlier cesarean delivery
  • Reason that prevents prostaglandin treatment
  • Reason that prevents vaginal birth, such as placenta previa, vasa previa or HIV with high viral load
  • Major fetal anomaly or fetal demise
  • Cannot give consent

This trial only enrols pregnant participants. The registry sentence this rests on: Gestational age between 34 weeks and 0 days and 42 weeks and 6 days

The registry criteria, word for word

Show all 19 criteriaShow less

Who can take part

  • Morbidly obese (BMI ≥ 40 kg/m2) at admission for induction of labor
  • Speaks English or Spanish
  • Gestational age between 34 weeks and 0 days and 42 weeks and 6 days
  • Age 18 years old or older
  • Viable, single, cephalic fetus
  • Intent to proceed with cervical ripening - cervical exam: dilation < 5 cm
  • Contractions < 5 per 10 minutes

Who cannot take part

  • Contraindication to prostaglandin administration (significant myomectomy, prior cesarean delivery)
  • History of cesarean delivery
  • Contraindication to vaginal delivery (placenta previa, vasa previa, HIV with high viral load)
  • Contraindications to labor (cardiac, neurosurgical, need for cesarean)
  • Significant vaginal bleeding with concern for placental abruption
  • Non-reassuring fetal status or fetal heart rate decelerations
  • Age < 18yo
  • Fetal growth restriction with abnormal umbilical artery Doppler indices
  • Cervical dilation >5 cm
  • Contractions >5 per 10 minutes
  • Fetal demise or major fetal anomaly
  • Inability to give consent

Where in United States

  • University of Maryland Medical CenterBaltimore, United StatesContact: Rosa Drummond, MDTaking people

About the trial

What the trial wants to find out

The goal of this randomized control trial is to compare different doses of Misoprostol (25 mcg vs 50 mcg) in induction of labor (IOL) in morbidly obese patients with BMI >40. It is known that morbid obesity is a risk factor for failed IOL and ultimately cesarean delivery (CD.) If the rates of vaginal delivery in this population can improve, then surgical morbidity can be reduced in these patients.

The 2 groups in the trial

  • Control - 25 mcg vaginal misoprostolExisting treatment, for comparison

    Participants will receive 25 mcg vaginal misoprostol every 4 hours.

    Treatment: Misoprostol

  • Intervention - 50 mcg vaginal misoprostolTreatment being tested

    Participants will receive 50 mcg vaginal misoprostol every 4 hours.

    Treatment: Misoprostol

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Induction of Labor in Morbidly Obese Patients: Comparison of 50 mcg and 25 mcg Misoprostol - A Randomized Control Trial
Plain-language title
Comparing two misoprostol doses to start labor in women with severe obesityGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
29 July 2026